Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -1.39% | 34.03 | 0.9% | $1163.63m | |
| JNJ | Johnson & Johnson | -0.12% | 142.81 | 0.7% | $1084.56m | |
| BMY | Bristol-Myers Squibb Co. | 0.18% | 60.30 | 1.0% | $985.23m | |
| MRK | Merck & Co., Inc. | -1.11% | 78.70 | 0.7% | $830.95m | |
| ABBV | AbbVie, Inc. | 0.41% | 99.42 | 1.9% | $788.32m | |
| LLY | Eli Lilly & Co. | -0.09% | 166.74 | 1.1% | $696.31m | |
| VXRT | Vaxart, Inc. | 37.73% | 8.87 | 0.0% | $300.02m | |
| AZN | AstraZeneca Plc | -1.15% | 53.48 | 1.2% | $295.19m | |
| RPRX | Royalty Pharma Plc | 2.04% | 47.05 | 0.1% | $233.45m | |
| NVS | Novartis AG | -0.75% | 87.80 | 0.2% | $155.51m | |
| RGEN | Repligen Corp. | -1.94% | 124.14 | 7.1% | $117.72m | |
| GSK | GlaxoSmithKline Plc | -1.56% | 40.37 | 0.2% | $117.39m | |
| NVO | Novo Nordisk A/S | -1.31% | 65.06 | 0.1% | $94.47m | |
| RETA | Reata Pharmaceuticals, Inc. | -2.99% | 155.64 | 3.4% | $81.74m | |
| SNY | Sanofi | -1.48% | 51.43 | 0.2% | $73.80m |
Company Profile
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.